We are live on ! Find out more

6 hedge funds and large institutions have $1.51M invested in Daxor in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.01% less ownership

Funds ownership: 4.22% → 3.21% (-1%)

14% less funds holding

Funds holding: 7 → 6 (-1)

16% less capital invested

Capital invested by funds: $1.8M → $1.51M (-$293K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DXR Hedge Fund Activity: Q3 2021 in Review

6 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q3 2021, worth a combined $1.51M — down 16% from $1.8M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DXR and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 0 added.

The largest seller was Sabby Management, cutting an estimated $403K.

  • 6 institutional investors held Daxor (DXR) as of Q3 2021, down from 7 in Q2 2021.
  • Funds reported $1.51M of Daxor stock for Q3 2021, down 16% quarter-over-quarter.
  • 0 funds opened new Daxor positions in Q3 2021 and 1 closed out, a net change of -1 holder.
  • The largest Daxor seller in Q3 2021 was Sabby Management, an estimated $403K sold.

Based on aggregated 13F filings for Q3 2021.